Press Releases
June 6, 2022
Sionna Therapeutics Announces Appointment of Paul Clancy to Board of Directors
Read more
April 19, 2022
Sionna Therapeutics Launches with $111 Million Series B Financing to Advance Pipeline of Novel Small Molecules with the Potential to Fully Restore CFTR Function in Cystic Fibrosis
Read more
Supporting Scientific Literature
Nature Chemical Biology | August 2, 2021
Journal of Cystic Fibrosis | January 3, 2020
Journal of Molecular Biology | January 16, 2015
Journal of Cystic Fibrosis | March 14, 2014
Nature Chemical Biology | May 12, 2013
Cell | January 20, 2012
PLOS ONE | November 30, 2010